United States:
Can The DPA Make A Dent In The Vaccine Supply Needs Of The COVID-19 Pandemic?
28 January 2021
Winston & Strawn LLP
To print this article, all you need is to be registered or login on Mondaq.com.
President Biden's team has unveiled several pandemic
response initiatives including using the U.S. Defense Production
Act (DPA), rejoining the World Health Organization, and providing
more direct federal involvement in the vaccine supply chain
planning. Winston & Strawn Partners Winston Kirton and Reed
Stephens spoke with Biopharma Reporter on what the Biden team
can do with these tools.
Read the full article here.
Visit Winston & Strawn's U.S. Election / Global Impact series for
our perspectives on cross-border issues impacted by the U.S.
election.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Coronavirus (COVID-19) from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.